Late gadolinium enhancement and the risk of ventricular arrhythmias and sudden death in NYHA I patients with non-ischemic cardiomyopathy.
Sign Up to like & getrecommendations! Published in 2023 at "European journal of heart failure"
DOI: 10.1002/ejhf.2793
Abstract: AIMS To compare the risk of ventricular arrhythmias (VA) and sudden death (SD) between NYHA I and NYHA II-III patients with non-ischemic cardiomyopathy (NICM). METHODS AND RESULTS Observational retrospective cohort study including patients with NICM… read more here.
Keywords: nyha iii; endpoint; nyha patients; death ... See more keywords
Pas d’interaction entre le bénéfice cardiovasculaire procuré par le liraglutide dans l’étude LEADER et l’existence d’une insuffisance cardiaque
Sign Up to like & getrecommendations! Published in 2018 at "Annales d'Endocrinologie"
DOI: 10.1016/j.ando.2018.06.209
Abstract: Objectifs Analyse post-hoc de l’etude LEADER selon la presence ou non d’antecedents d’insuffisance cardiaque (IC) NYHA II–III. Methodes Dans LEADER, 9340 DT2 a haut risque CV ont ete randomises (1 :1) pour recevoir liraglutide ou un placebo (plus… read more here.
Keywords: insuffisance cardiaque; nyha iii; des antecedents; leader ... See more keywords